EP3149190A4 - Identification of novel anti-persister activity for borrelia burgdorferi - Google Patents
Identification of novel anti-persister activity for borrelia burgdorferi Download PDFInfo
- Publication number
- EP3149190A4 EP3149190A4 EP15788973.4A EP15788973A EP3149190A4 EP 3149190 A4 EP3149190 A4 EP 3149190A4 EP 15788973 A EP15788973 A EP 15788973A EP 3149190 A4 EP3149190 A4 EP 3149190A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- identification
- novel anti
- borrelia burgdorferi
- persister
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
- C12Q1/06—Quantitative determination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N2021/6439—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks
- G01N2021/6441—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks with two or more labels
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6456—Spatial resolved fluorescence measurements; Imaging
- G01N21/6458—Fluorescence microscopy
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Optics & Photonics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461990759P | 2014-05-09 | 2014-05-09 | |
US201461990766P | 2014-05-09 | 2014-05-09 | |
US201462073605P | 2014-10-31 | 2014-10-31 | |
US201562136678P | 2015-03-23 | 2015-03-23 | |
PCT/US2015/024122 WO2015171225A1 (en) | 2014-05-09 | 2015-04-02 | Identification of novel anti-persister activity for borrelia burgdorferi |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3149190A1 EP3149190A1 (en) | 2017-04-05 |
EP3149190A4 true EP3149190A4 (en) | 2018-04-18 |
Family
ID=54392835
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP15788973.4A Withdrawn EP3149190A4 (en) | 2014-05-09 | 2015-04-02 | Identification of novel anti-persister activity for borrelia burgdorferi |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP3149190A4 (zh) |
CN (1) | CN107148480A (zh) |
WO (1) | WO2015171225A1 (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20180246095A1 (en) * | 2015-08-19 | 2018-08-30 | The Johns Hopkins University | Compositions and methods for diagnosing and treating lyme disease |
EP3252470B1 (en) | 2016-06-03 | 2020-07-29 | Te?ted Oy | A method and a solid support for detecting tick-borne microbes in a biological sample |
CN108570032B (zh) * | 2017-03-09 | 2021-04-02 | 华东理工大学 | 新型罗丹明染料及其在抗致病菌中的应用 |
WO2020019289A1 (zh) * | 2018-07-27 | 2020-01-30 | 华东理工大学 | 新型罗丹明染料及其在抗致病菌中的应用 |
CN109620979B (zh) * | 2018-12-29 | 2020-09-01 | 福建师范大学 | 低离子休克提高氨基糖苷类抗生素杀灭持留菌效率的方法 |
GB202118957D0 (en) * | 2021-12-23 | 2022-02-09 | Univ Liverpool | Dyes and uses thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070042453A1 (en) * | 2005-08-22 | 2007-02-22 | Novak John S | High throughput screening method for antimicrobial formulations |
US20100130437A1 (en) * | 2007-07-25 | 2010-05-27 | Gustave Huber | Topical antibiotic composition for the prevention of lyme disease |
US20130084625A1 (en) * | 2011-09-30 | 2013-04-04 | Advanced Laboratory Services, Inc. | Compositions and methods for culturing spirochetes |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5932437A (en) * | 1998-04-13 | 1999-08-03 | Genesis Laboratories, Inc. | Control of lyme disease spirochete |
CN101568262A (zh) * | 2005-07-20 | 2009-10-28 | 斯克利普斯研究院 | 在哺乳动物对象中治疗革兰氏阳性细菌感染的组合物和方法 |
WO2007070084A1 (en) * | 2005-12-15 | 2007-06-21 | Activbiotics, Inc. | Uses of rifamycins |
CN101762684A (zh) * | 2008-12-24 | 2010-06-30 | 上海市计划生育科学研究所 | 一种体外检测精子存活率的方法 |
-
2015
- 2015-04-02 CN CN201580037580.4A patent/CN107148480A/zh active Pending
- 2015-04-02 WO PCT/US2015/024122 patent/WO2015171225A1/en active Application Filing
- 2015-04-02 EP EP15788973.4A patent/EP3149190A4/en not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070042453A1 (en) * | 2005-08-22 | 2007-02-22 | Novak John S | High throughput screening method for antimicrobial formulations |
US20100130437A1 (en) * | 2007-07-25 | 2010-05-27 | Gustave Huber | Topical antibiotic composition for the prevention of lyme disease |
US20130084625A1 (en) * | 2011-09-30 | 2013-04-04 | Advanced Laboratory Services, Inc. | Compositions and methods for culturing spirochetes |
Non-Patent Citations (6)
Title |
---|
BARBESTI S ET AL: "TWO AND THREE-COLOR FLUOROESCENCE FLOW CYTOMETRIC ANALYSIS OF IMMUNOIDENTIFIED VIABLE BACTERIA", CYTOM, ALAN LISS, NEW YORK, US, vol. 40, no. 3, 1 July 2000 (2000-07-01), pages 214 - 218, XP009042629, ISSN: 0196-4763, DOI: 10.1002/1097-0320(20000701)40:3<214::AID-CYTO6>3.0.CO;2-M * |
LAKOS A ET AL: "[Effect of an antibiotic combination on the propagation of Borrelia burgdorferi, causative agent of Lyme disease].", ORVOSI HETILAP 04 JUL 1999, vol. 140, no. 27, 4 July 1999 (1999-07-04), pages 1529 - 1532, XP009501949, ISSN: 0030-6002 * |
MARC RÜGER ET AL: "A flow cytometric method for viability assessment of Staphylococcus aureus and Burkholderia cepacia in mixed culture", CYTOMETRY. PART A, vol. 81A, no. 12, 18 October 2012 (2012-10-18), US, pages 1055 - 1066, XP055429410, ISSN: 1552-4922, DOI: 10.1002/cyto.a.22219 * |
RAPHAEL STRICKER ET AL: "Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi", INFECTION AND DRUG RESISTANCE, 1 May 2011 (2011-05-01), pages 97, XP055080660, DOI: 10.2147/IDR.S19201 * |
See also references of WO2015171225A1 * |
THOMAS C A ET AL: "FLUOROMETRIC ASSESSMENTS OF ACROSOMAL INTEGRITY AND VIABILITY IN CRYOPRESERVED BOVINE SPERMATOZOA", BIOLOGY OF REPRODUCTION, NEW YORK, NY [U.A.] : ACADEM. PRESS, US, vol. 56, 1 January 1997 (1997-01-01), pages 991 - 998, XP002924037, ISSN: 0006-3363, DOI: 10.1095/BIOLREPROD56.4.991 * |
Also Published As
Publication number | Publication date |
---|---|
WO2015171225A1 (en) | 2015-11-12 |
EP3149190A1 (en) | 2017-04-05 |
CN107148480A (zh) | 2017-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3102576B8 (en) | Dihydropyrrolopyridine inhibitors of ror-gamma | |
EP3193600A4 (en) | Smyd inhibitors | |
IL246785A0 (en) | Benzimidazole-2-amines as midh1 inhibitors | |
EP3314504A4 (en) | METHOD FOR THE DISTRIBUTED OPERATION OF SAFE CONTROL DEVICES | |
EP3119772B8 (en) | Heteroaryl syk inhibitors | |
EP3137169A4 (en) | Inhibitors of lysine specific demethylase-1 | |
EP3127420A4 (en) | Cultivation system | |
EP3116503A4 (en) | Hptp-beta inhibitors | |
EP3189038A4 (en) | Inhibitors of lysine specific demethylase-1 | |
EP3160956A4 (en) | Inhibitors of lysine specific demethylase-1 | |
EP3166608A4 (en) | Aminopyridazinone compounds as protein kinase inhibitors | |
EP3096693A4 (en) | Spring-fit surgical guides | |
HK1226398A1 (zh) | 作為midh1抑制劑的苯並咪唑-2-胺 | |
EP3164380A4 (en) | Inhibitors of lysine specific demethylase-1 | |
EP3102034A4 (en) | Aminotriazole- and aminotetrazole-based kdm1a inhibitors as epigenetic modulators | |
EP3164509A4 (en) | Inhibitors of lysine specific demethylase-1 | |
EP3096694A4 (en) | Skin-referencing surgical guides | |
EP3183255A4 (en) | Spiropyrrolidines as mdm2 inhibitors | |
EP3156017A4 (en) | Absorbent product | |
EP3142667A4 (en) | Methods for inhibiting necroptosis | |
EP3095042A4 (en) | Consensus sequence identification | |
EP3099265A4 (en) | Interfaces for surgical systems | |
EP3123994A4 (en) | Absorbent product | |
EP3234895A4 (en) | Assurance of identity information | |
EP3149190A4 (en) | Identification of novel anti-persister activity for borrelia burgdorferi |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20170206 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
RIC1 | Information provided on ipc code assigned before grant |
Ipc: G01N 33/50 20060101ALI20171208BHEP Ipc: G01N 21/25 20060101ALI20171208BHEP Ipc: A61K 31/00 20060101ALI20171208BHEP Ipc: C12Q 1/06 20060101AFI20171208BHEP Ipc: A61K 38/00 20060101ALI20171208BHEP Ipc: G01N 21/64 20060101ALI20171208BHEP Ipc: C12Q 1/18 20060101ALI20171208BHEP |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20180319 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: G01N 21/64 20060101ALI20180313BHEP Ipc: G01N 33/50 20060101ALI20180313BHEP Ipc: A61K 31/00 20060101ALI20180313BHEP Ipc: A61K 38/00 20060101ALI20180313BHEP Ipc: C12Q 1/18 20060101ALI20180313BHEP Ipc: G01N 21/25 20060101ALI20180313BHEP Ipc: C12Q 1/06 20060101AFI20180313BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20181101 |